Elsbet Pieterman

Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates

Ermond van Beek, Elsbet Pieterman, Louis Cohen et al. · Biochemical and Biophysical Research Communications · 1999 · 502 citations

Biosynthesis, Aldo-keto Reductase, Biochemistry +9

Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT‐1 pathway between rheumatoid tissues

Tineke C. T. M. van der Pouw Kraan, F. van Gaalen, Pia V. Kasperkovitz et al. · Arthritis & Rheumatism · 2003 · 258 citations · Full text

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice

Christine Landlinger, Marianne Pouwer, Claudia Juno et al. · European Heart Journal · 2017 · 217 citations · Full text

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin

Susan Kühnast, José W.A. van der Hoorn, Elsbet Pieterman et al. · Journal of Lipid Research · 2014 · 202 citations · Full text

Nitrogen-Containing Bisphosphonates Inhibit Isopentenyl Pyrophosphate Isomerase/Farnesyl Pyrophosphate Synthase Activity with Relative Potencies Corresponding to Their Antiresorptive Potenciesin Vitroandin Vivo

Ermond van Beek, Elsbet Pieterman, Louis Cohen et al. · Biochemical and Biophysical Research Communications · 1999 · 194 citations

Biochemistry, Medicine, Relative Potencies Corresponding +4